Dr. Barry White shares cases of challenging melanocytic lesions in which gene expression profiling (GEP) was utilized to inform the diagnosis when histopathological findings were insufficient to render a definitive diagnosis

Dr. Drazen Jukic presents challenging cases in which gene expression profiling (GEP) was utilized to inform the diagnosis of ambiguous melanocytic lesions.

The spatialomics approach of TissueCypher brings precision pathology to the clinic for more personalized care of patients with BE to improve outcomes.

The TissueCypher test may enable physicians to target EET for high-risk BE patients, while reducing unnecessary procedures in low-risk patients.

Drs. Trotter and Sligh hosted a live Q&A session on the content discussed in this webinar. Register for free to be part of the webinar. This activity has been developed to meet the educational needs of dermatologists, nurse practitioners, physician assistants, and staff who are dedicated to the management of patients with cutaneous melanoma and cutaneous squamous cell carcinoma

The TissueCypher assay would be cost-effective after 5 years and improves patient outcomes by improving effectiveness of surveillance and treatment protocols.

A tissue systems pathology test may provide an objective method to facilitate earlier therapeutic intervention of Barrett's esophagus patients.

Detection of the field effect in the clinical setting with validated, cost-effective diagnostic assays may increase the detection of HGD and EAC.

Barrett’s esophagus management decisions are often based on subjective diagnoses, so better information and techniques are needed to aid in BE patient care

Exploration of a tissue systems pathology approach to predict progression in patients with non-dysplastic Barrett's esophagus.